tiprankstipranks
Actinium Pharmaceuticals (ATNM)
:ATNM
US Market

Actinium Pharmaceuticals (ATNM) Income Statement

Compare
2,178 Followers

Actinium Pharmaceuticals Income Statement

Last quarter (Q3 2024), Actinium Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Actinium Pharmaceuticals's net income was $-11.57M. See Actinium Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 81.00K$ 1.03M$ 1.14M$ 0.00$ 0.00
Gross Profit
$ 81.00K$ 331.00K$ 620.00K$ -447.00K$ -420.09K
Operating Expenses
$ 52.00M$ 35.13M$ 26.11M$ 22.39M$ 22.07M
Depreciation and Amortization
$ 790.00K$ 699.00K$ 524.00K$ 447.00K$ 420.09K
EBITDA
$ -51.13M$ -33.41M$ -24.44M$ -21.77M$ -21.48M
Operating Income
$ -51.92M$ -34.10M$ -24.96M$ -22.39M$ -22.07M
Other Income/Expenses
$ 3.10M$ 1.09M$ 190.00K$ 178.00K$ 172.39K
Pretax Income
$ -48.82M$ -33.02M$ -24.77M$ -22.21M$ -21.90M
Net Income
$ -48.82M$ -31.93M$ -24.58M$ -22.04M$ -21.73M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.83$ -1.32$ -1.20$ -1.82$ -4.37
Diluted EPS
$ -1.83$ -1.32$ -1.20$ -1.82$ -4.37
Weighted Average Shares Outstanding
26.60M 24.14M 20.57M 12.13M 4.98M
Weighted Average Shares Outstanding (Diluted)
26.60M 24.14M 20.57M 12.13M 4.98M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis